跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EGFR antagonists
首页
药物
EGFR antagonists
EGFR antagonists
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Bispecific anti-HER antibodies
CN 104447995 A
申请人: HOFFMANN LA ROCHE
优先权: 2009
CN
EP
US
8 件公开
GENE DETECTION ASSAY FOR IMPROVING THE LIKELIHOOD OF AN EFFECTIVE RESPONSE TO AN EGFR ANTAGONIST CANCER THERAPY
US 2007202516 A1
申请人: GENENTECH INC
优先权: 2000
CN
US
7 件公开
EGFR ANTAGONIST FOR THE TREATMENT OF HEART DISEASE
US 2013230581 A1
申请人: FENG QINGPING
优先权: 2011
CN
US
4 件公开
EGFR ANTAGONISTS FOR THE TREATMENT OF DISEASES INVOLVING UNWANTED MIGRATION, PROLIFERATION, AND/OR METAPLASIA OF RETINAL PIGMENT EPITHELIUM (RPE) CELLS
EP 4746970 A1
申请人: JONAS JOST B
优先权: 2023
CN
EP
WO
3 件公开
COMBINATION THERAPY WITH C-MET AND EGFR ANTAGONISTS
US 2009226443 A1
申请人: GENENTECH INC
优先权: 2009
CN
US
3 件公开
Epidermal growth factor receptor antagonists and methods of use
US 7470769 B2
申请人: MOLECULAR LOGIX INC
优先权: 2005
US
3 件公开
AGENT FOR PREVENTING AND/OR TREATING AMYOTROPHIC LATERAL SCLEROSIS
WO 2016114322 A1
申请人: UNIV KYOTO
优先权: 2015
CN
WO
2 件公开
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
US 2006035893 A1
申请人: BOEHRINGER INGELHEIM INT
优先权: 2004
US
2 件公开
US 2010099651 A1
申请人: BOEHRINGER INGELHEIM INT
优先权: 2007
US
Pharmaceutical compositions based on anticholinergics and additional active ingredients
US 7776315 B2
申请人: BOEHRINGER INGELHEIM PHARMA
优先权: 2004
US
2 件公开
Pharmaceutical Composition Containing Antagonist of EGF Family Ligand as Component
US 2012141501 A1
申请人: YOSHIDA KENJI
优先权: 2009
US
2 件公开
第 1 / 3 页
上一页
下一页
药物
反馈